EU · REG · 1223/2009 Consumer Advisory Est · MMXXVI
BANNED in Europe Banned in Europe
Explainers

What the EU Just Banned in Cosmetics in 2026

A new regulation, Omnibus VIII, added a batch of substances to Europe's prohibited and restricted cosmetics lists this spring. Most of the names mean nothing to you, and that's actually the interesting part.

By 8 min read Explainers

Every so often a headline goes around claiming the EU has “banned dozens of chemicals in cosmetics” while America does nothing. This spring there was a real regulation behind one of those headlines, and it’s worth looking at honestly, because the truth is both less dramatic and more interesting than the clickbait version.

The regulation is called Omnibus VIII, formally Commission Regulation (EU) 2026/78. It was published in January 2026 and took effect on May 1, 2026 (HPRA summary of Omnibus VIII). It added a batch of newly classified CMR substances to the EU’s lists of ingredients that are prohibited or restricted in cosmetics: more than a dozen moved onto the prohibited list, with related changes to the restricted-substance annexes. The Commission’s own proposal targeted 15 CMR substances for the ban, with further revisions across Annexes III to V (CIRS Group on the proposal).

So far, so “EU bans chemicals.” But read the actual list and something jumps out.

The names nobody recognizes

Here are some of the substances Omnibus VIII moved onto the prohibited list: perboric acid, certain carbon nanotubes, acetone oxime, and various forms of silver at the nanoscale (Cosmeservice on the new CMR restrictions).

If those names mean nothing to you, that’s not a gap in your knowledge. It’s the point. These aren’t the parabens and dyes and sunscreen filters people argue about online. They’re mostly industrial or niche substances that were rarely, in some cases never, used in the cosmetics on your shelf. One substance, hexyl salicylate, went the other way: the EU’s safety committee judged it safe under specific conditions and added it to the restricted list rather than banning it, which tells you the process isn’t a blunt instrument (UL Solutions on the annex updates).

This is why the “EU banned dozens of chemicals” framing is technically true and practically misleading. Yes, the list grew. No, your moisturizer was probably not affected, because the things on it weren’t in your moisturizer to begin with.

The mechanism is the actual story

So if the substances themselves are obscure, what’s worth understanding? The machine that put them there. Because that machine is the real difference between Europe and the United States, and it runs on autopilot.

Here’s how it works. The EU has a separate body of law, called CLP, that classifies chemicals by hazard. When a substance gets formally classified as a CMR, meaning carcinogenic, mutagenic, or toxic for reproduction, in categories 1A, 1B, or 2, a gear engages in the cosmetics regulation. Under the EU Cosmetics Regulation, CMR-classified substances are prohibited in cosmetics by default. A company can apply for a narrow exemption if it can prove a specific substance is safe and necessary with no alternative, but absent that, the ban is automatic.

That’s exactly what Omnibus VIII did. The substances it banned had recently been reclassified as CMR under a 2024 hazard-classification update, and because no one filed (or won) an exemption for them, they flowed straight onto the prohibited list (CIRS Group on the CMR controls). No new debate about each individual ingredient. No separate campaign. Classify the hazard, and the cosmetics ban follows on rails.

The “omnibus” name captures it: this is a routine, periodic housekeeping regulation, the eighth of its kind, that sweeps newly classified CMR substances into the cosmetics prohibition in one batch. It happens on a schedule. It is, in the most literal sense, the precautionary principle automated.

Why the US has nothing like this

Now the contrast, and I’ll keep it calibrated rather than cheerleading.

The United States has no equivalent automatic pipeline. There’s no federal rule that says “if a substance is classified as a carcinogen, it is hereby banned from cosmetics.” US cosmetics law was, for decades, famously thin: the core statute dates to 1938 and gave the FDA limited power to keep ingredients out before harm was shown. The 2022 Modernization of Cosmetics Regulation Act (MoCRA) expanded the FDA’s authority over cosmetics for the first time in generations, adding registration, adverse-event reporting, and safety-substantiation requirements. But even MoCRA didn’t build the automatic hazard-to-ban gear the EU runs. American cosmetics regulation is still mostly substance-by-substance, slower, and more reactive.

So the structural gap is real, and Omnibus VIII is a clean illustration of it. Europe bans a class of newly classified substances in a single scheduled stroke; the US would need a specific rulemaking for each, and rarely undertakes it.

But here’s the honest other half. The automatic mechanism’s strength is also its limitation. Banning by hazard classification, rather than by real-world exposure and risk, means the EU sometimes prohibits substances that posed little practical danger in the way they were actually used, or weren’t meaningfully used at all. A hazard is what a substance could do at some dose; a risk is what it’s likely to do at the dose you actually encounter. The EU’s system leans hard toward hazard. That’s a defensible choice, and it’s not a free one: it can spend regulatory attention and industry effort on substances that were never realistically going to hurt anyone, which is part of why so many Omnibus entries are names you’ve never seen on a label.

What to actually take from this

If you want the practical bottom line: Omnibus VIII almost certainly didn’t change what’s in your bathroom. The banned substances were mostly obscure, and the one consumer-adjacent move (hexyl salicylate) was a restriction, not a ban.

What it does show is the thing this site keeps coming back to. The EU and US don’t just disagree about individual ingredients. They run on different operating systems. Europe’s defaults toward prohibition-by-classification, on a schedule, automatically. America’s defaults toward permission until a specific problem is proven, ingredient by ingredient. Neither is simply “safer.” One catches genuinely worrying substances early and also sweeps up harmless ones. The other avoids overreach and also lets real problems linger for years.

Omnibus VIII is a small, dull-looking regulation. But it’s a clean window into why a European label and an American label can end up so different, and why the reason is rarely a single scary chemical. It’s the machine behind the label, quietly doing what it was built to do.

Sources